What I’ve Learned: Lessons and Advice from a Veteran of the Panama Papers Investigation

Several years ago a whistleblower reached out to the German newspaper Süddeutsche Zeitung with an enticing message: “Hello, this is John Doe… Interested in data?” That story would become the Panama Papers, the first in a number of international collaborations for investigative reporter Frederik Obermaier. Read his tips and advice about investigative reporting.

2022’s Best Investigative Stories from Turkey

In Turkey, authoritarianism is increasingly undermining media pluralism and is limiting the freedom of journalists to report and receive information now more than ever before. Despite this, GIJN Turkish found numerous praiseworthy stories produced by watchdog reporters this year, and here feature eight notable examples of investigative journalism, photojournalism, and documentary work. 

GIJN Toolbox: Hunting for Secret Money and Financial Conflicts of Interest

In this edition of GIJN Toolbox, we profile three brand new — or newly expanded — tools to dig into financial secrecy and hidden gains from corruption or crime. Our list includes a user-friendly database to search for sanctions and conflict-of-interest red flags, a site that uses an algorithm to detect hidden bank accounts, and a newly expanded database on the true owners of offshore companies.

Health and Medicine Guide: Chapter 1

 
Regulating Drugs: Development & Approval
Tip 1: Dig Deeper into Development & Approval
If your story is about drugs, it is essential to delve into their development and approval history. There’s a trove of valuable information.

Guía de GIJN sobre investigación periodística en salud y medicina: Capítulo 1

 
Regulación de medicamentos: desarrollo y autorización
Primera sugerencia: profundiza en el desarrollo y la aprobación
Si tu historia trata el tema de los medicamentos, es esencial profundizar en su desarrollo y aprobación. Aunque todos los países tienen su propia agencia reguladora (véase en el apéndice), el trabajo de la Agencia Estadounidense de Alimentos y Medicamentos (FDA, Food and Drug Administration) y la Agencia Europea de Medicamentos (EMA, European Medicines Agency) tienen una gran influencia en el mercado farmacéutico mundial.